<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1821">
  <stage>Registered</stage>
  <submitdate>31/01/2008</submitdate>
  <approvaldate>31/01/2008</approvaldate>
  <nctid>NCT00614211</nctid>
  <trial_identification>
    <studytitle>Laparoscopic Approach to Cervical Cancer</studytitle>
    <scientifictitle>A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy Versus Abdominal Radical Hysterectomy in Patients With Early Stage Cervical Cancer</scientifictitle>
    <utrn />
    <trialacronym>LACC</trialacronym>
    <secondaryid>LACC001</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cervical Cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Womb (Uterine or endometrial cancer)</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Cervical (cervix)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Total Abdominal Radical Hysterectomy
Treatment: surgery - Total Laparoscopic or Robotic Radical Hysterectomy

Active Comparator: 1 - Total Abdominal Radical Hysterectomy

Experimental: 2 - Total Laparoscopic or Robotic Radical Hysterectomy


Treatment: surgery: Total Abdominal Radical Hysterectomy
In a radical hysterectomy the uterus, the upper one to two centimetres of the vagina and the soft tissues around the cervix are excised.

Treatment: surgery: Total Laparoscopic or Robotic Radical Hysterectomy
In a radical hysterectomy the uterus, the upper one to two centimetres of the vagina and the soft tissues around the cervix are excised.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Disease free survival</outcome>
      <timepoint>5 years from surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patterns of recurrence</outcome>
      <timepoint>5 years from surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Costs</outcome>
      <timepoint>6 months from surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life</outcome>
      <timepoint>6 months from surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Pelvic Floor Distress Inventory</outcome>
      <timepoint>5 years from surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Overall survival</outcome>
      <timepoint>5 years from surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Feasibility of sentinel lymph node biopsy</outcome>
      <timepoint>Intra-operatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Intra-operative, peri-operative, post-operative and long term treatment related morbidity</outcome>
      <timepoint>6 months from surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or
             adenosquamous carcinoma of the uterine cervix;

          -  Patients with Histologically confirmed stage IA1 (with lymph vascular invasion), stage
             IA2, or stage IB1 disease

          -  Patients undergoing either a Type II or III radical hysterectomy (Piver
             Classification)

          -  Patients with adequate bone marrow, renal and hepatic function:

          -  ECOG Performance Status of 0 or 1.

          -  Patient must be suitable candidates for surgery.

          -  Patients who have signed an approved Informed Consent

          -  Patients with a prior malignancy allowed if &gt; 5 years ago with no current evidence of
             disease

          -  Females, aged 18 years or older

          -  Negative serum pregnancy test within &lt;30 days of surgery in pre-menopausal women and
             women &lt; 2 years after the onset of menopause</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Any histology other than adenocarcinoma, squamous cell carcinoma or adenosquamous
             carcinoma of the uterine cervix;

          -  Tumor size greater than 4 cm;

          -  FIGO stage II-IV;

          -  Patients with a history of pelvic or abdominal radiotherapy;

          -  Patients who are pregnant;

          -  Patients with contraindications to surgery;

          -  Patients with evidence of metastatic disease by conventional imaging studies, enlarged
             pelvic or aortic lymph nodes &gt; 2cm; or histologically positive lymph nodes

          -  Unfit for Surgery: serious concomitant systemic disorders incompatible with the study
             (at the discretion of the investigator);

          -  Patients unable to withstand prolonged lithotomy and steep Trendelenburg position

          -  Patient compliance and geographic proximity that do not allow adequate follow-up</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>740</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/07/2022</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD,WA</recruitmentstate>
    <hospital>The Wesley Hospital - Auchenflower</hospital>
    <hospital>Greenslopes Private Hospital - Greenslopes</hospital>
    <hospital>Royal Brisbane and Women's Hospital - Herston</hospital>
    <hospital>Mater Health Services - South Brisbane</hospital>
    <hospital>The Townsville Hospital - Townsville</hospital>
    <hospital>Saint John of God - Murdoch</hospital>
    <hospital>King Edward Memorial Hospital - Subiaco</hospital>
    <hospital>Saint John of God - Subiaco</hospital>
    <postcode>4066 - Auchenflower</postcode>
    <postcode>4120 - Greenslopes</postcode>
    <postcode>4029 - Herston</postcode>
    <postcode>4101 - South Brisbane</postcode>
    <postcode>4814 - Townsville</postcode>
    <postcode> - Murdoch</postcode>
    <postcode> - Subiaco</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Nevada</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oklahoma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Wisconsin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>Cordoba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Parana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>San Paulo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Sao Paulo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>SP</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Bulgaria</country>
      <state>Pleven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state>Guangdong</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state>Zhejiang</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Medellin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Delhi</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Milan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Rome</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Republic of</country>
      <state>Seoul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Mexico City</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Peru</country>
      <state>Surquillo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Puerto Rico</country>
      <state>Caguas</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Queensland Centre for Gynaecological Cancer</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>M.D. Anderson Cancer Center</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The goal of this clinical research study is to compare the long-term outcomes of different
      surgical methods for the treatment of cervical cancer. The long-term outcome of a total
      abdominal radical hysterectomy (TARH) will be compared against laparoscopy. In this study,
      the laparoscopy will be done with or without robotic technology.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00614211</trialwebsite>
    <publication>Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PT. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):584-8. doi: 10.1016/j.jmig.2008.06.013.
</publication>
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Pedro Ramirez, M.D.</name>
      <address>M.D. Anderson Cancer Center</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Vanessa Behan, BNursing</name>
      <address />
      <phone>+61 7 3646 4343</phone>
      <fax />
      <email>Vanessa.Behan@health.qld.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>